A Clinical Evaluation of an Esterified Hyaluronic Acid Matrix in Burn Patients for STSG
NCT03723590 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5
Last updated 2023-09-06
Summary
Burn patients meeting inclusion criteria will receive the esterified hyaluronic acid matrix as the matrix for their wound, in conjunction with the standard of care for managing these types of wounds. The study will be divided into two phases. Phase I will entail intervention with the wound matrix and will continue until one of the following occur, sufficient granulation has occurred and the patient can receive a STSG and proceed to Phase II, the patient's physician determines an STSG is no longer necessary or two applications with the wound matrix occur and no STSG is approved. Phase II will begin following the STSG procedure. In this phase, the wound will be monitored and proportion of STSG take will be evaluated but no application of the wound matrix device will take place. This phase will continue for 28 days or if the physician deems the patient no longer needs regular care to monitor the wound, whichever occurs earlier.
Conditions
- Burn Wound
Interventions
- DEVICE
-
Esterified Hyaluronic Acid Matrix
A non-woven pad composed of esterified hyaluronic acid, covered with a semipermeable silicone layer to protect the wound and control water vapor loss
Sponsors & Collaborators
-
Medline Industries
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-02-06
- Primary Completion
- 2021-09-22
- Completion
- 2021-09-22
- FDA Device
- Yes
More Related Trials
-
A Clinical Study of Allogeneic Human Dermal Fibroblasts for Remodeling Scar Contractures
NCT01564407 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
A DERMO-EPIDERMAL AUTOLOGOUS SKIN SUBSTITUTE FOR FURTHER THERAPEUTIC USE
NCT04925323 ·Status: UNKNOWN ·Phase: NA
-
Pilot Study of Azficel-T for the Treatment of Restrictive Burn Scars
NCT01858753 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy of Application of Myriad Matrix to Split Thickness Skin Graft Sites
NCT06647394 ·Status: WITHDRAWN
-
Study With an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Adults and Adolescents
NCT03227146 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Randomized Comparison Study of Aquacel Ag and Glucan II as Donor Site Dressings
NCT00581217 ·Status: TERMINATED
-
Burn Study- Tranexamic Acid Versus Thrombin in Split Thickness Skin Graft
NCT06379724 ·Status: RECRUITING ·Phase: PHASE4
-
The Dermisgraft Epithelialization and Late Scar Healing
NCT05189743 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study of Autologous Engineered Skin Substitute to Treat Partial- and Full-Thickness Burn Wounds
NCT01655407 ·Status: UNKNOWN ·Phase: PHASE2
-
Single-Stage Integra Reconstruction in Burns
NCT03077087 ·Status: TERMINATED ·Phase: NA
-
Safety and Efficacy Study of Fibrin Sealant (FS 4IU) for Skin Graft Fixation and Wound Healing in Subjects With Burn Wounds
NCT00161759 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Controlled Comparison of a Traditional Dressing Versus a Biologic Dressing Composed of Fetal Fibroblasts and Keratinocytes in Association With a Collagen Matrix on Skin Donor Sites
NCT03334656 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
An Acellular Epithelial Skin Substitute in Deep Partial-thickness Burns
NCT01454310 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of ACell Hydrated Wound Dressing for Autogenous Skin Donor Sites
NCT00352729 ·Status: WITHDRAWN ·Phase: NA
-
Microsurfaced Grafts in Deep Burn Wounds
NCT04589442 ·Status: RECRUITING ·Phase: PHASE4
-
StrataGraft® Skin Tissue as an Alternative to Autografting Full-thickness Complex Skin Defects
NCT03005054 ·Status: TERMINATED ·Phase: PHASE2
-
Dermal Substitute and Topical Negative Pressure in Burns
NCT00548314 ·Status: COMPLETED ·Phase: PHASE3
-
StrataGraft Overlay of Meshed Autograft in Full-thickness Thermal Burns
NCT04765202 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Safety and Efficacy of realSKIN® to Provide Complete Wound Closure of Burn Wounds as an Alternative to Autografting
NCT06223269 ·Status: RECRUITING ·Phase: PHASE3
-
Pilot Safety and Efficacy Study of Isolagen Therapy in Treatment of Restrictive Burn Scars
NCT00620737 ·Status: WITHDRAWN ·Phase: PHASE2
-
Biological Skin Graft With Keratinocyte-stem Cell Co-cultre for Burn Patients
NCT05652816 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Study of Silicone Material Inserts To Treat Burn Scars
NCT03159182 ·Status: WITHDRAWN ·Phase: NA
-
Efficacy of a Photosynthetic Dermal Matrix for the Treatment of Full-Thickness Skin Wounds
NCT07157657 ·Status: RECRUITING ·Phase: PHASE2
-
Non-cultured Autologous Keratinocyte Suspension Versus Traditional Split Skin Graft for Burn Wounds Treatment
NCT03675568 ·Status: WITHDRAWN ·Phase: NA
-
Allogeneic ADSCs and Platelet-Poor Plasma Fibrin Hydrogel to Treat the Patients With Burn Wounds (ADSCs-BWs)
NCT03113747 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2